Sinopharm Medicine Holding Tianjin Co Ltd is a wholly-owned subsidiary of Sinopharm Group Co Ltd (Sinopharm Holding). The company primarily engages in pharmaceuticals and medical device consumables, as well as other health-related products.
Established in 1952, the company has over the past seventy years consistently adhered to the corporate philosophy of "all for health, health for all”. Relying on professional marketing channels and networks, it has made outstanding contributions to the safe use of medicines and the health of the general public.
The company is a national central medical reserve unit and an authorized operator for anesthetics, psychotropic drugs and vaccine products. In 2022, it achieved tax-excluded sales of 12.5 billion yuan ($1.77 billion), ranking first among pharmaceutical distribution companies in Tianjin. It has been honored with the titles of Top 100 Enterprise in Tianjin and Top 100 Service Enterprise in Tianjin.
In March 2018, the company's headquarters was awarded the title of National Model Unit. In 2020, the company was awarded the title of Tianjin Model Unit 2018-2020 and retained the title of National Model Unit. In the same year, the CPC committee of the company won the honorary title of Advanced Grassroots Party Organization in Tianjin by the Tianjin Municipal Committee of the Communist Party of China. In 2022, the company was conferred with the Tianjin May Day Labor Award by the Tianjin Municipal Trade Union.
The company places great importance on the building of model units. It views the honor of being a National Model Unit as a driving force to propel operational and managerial advancements, as well as to enhance its overall corporate management and improve the comprehensive qualities of the workforce. By continuously promoting the establishment of a sound long-term mechanism and enhancing work efficiency and services, the company has realized harmonious, healthy and innovative development, earning recognition and praise from employees and various sectors of society.
The company has fulfilled its social responsibilities by establishing volunteer service teams. During the COVID-19 pandemic, it supplied pandemic prevention materials and stored and distributed COVID-19 vaccines in Tianjin. These moves contributed to the smooth and orderly progress of Tianjin’s pandemic response, building a solid immune barrier for Beijing, the capital of China.
The company has actively served the communities and society, ensured medication safety for the general public, and made contributions to a healthy China.
Sinopharm Medicine Holding Tianjin Co Ltd is a wholly-owned subsidiary of Sinopharm Group Co Ltd (Sinopharm Holding). The company primarily engages in pharmaceuticals and medical device consumables, as well as other health-related products.
Established in 1952, the company has over the past seventy years consistently adhered to the corporate philosophy of "all for health, health for all”. Relying on professional marketing channels and networks, it has made outstanding contributions to the safe use of medicines and the health of the general public.
The company is a national central medical reserve unit and an authorized operator for anesthetics, psychotropic drugs and vaccine products. In 2022, it achieved tax-excluded sales of 12.5 billion yuan ($1.77 billion), ranking first among pharmaceutical distribution companies in Tianjin. It has been honored with the titles of Top 100 Enterprise in Tianjin and Top 100 Service Enterprise in Tianjin.
In March 2018, the company's headquarters was awarded the title of National Model Unit. In 2020, the company was awarded the title of Tianjin Model Unit 2018-2020 and retained the title of National Model Unit. In the same year, the CPC committee of the company won the honorary title of Advanced Grassroots Party Organization in Tianjin by the Tianjin Municipal Committee of the Communist Party of China. In 2022, the company was conferred with the Tianjin May Day Labor Award by the Tianjin Municipal Trade Union.
The company places great importance on the building of model units. It views the honor of being a National Model Unit as a driving force to propel operational and managerial advancements, as well as to enhance its overall corporate management and improve the comprehensive qualities of the workforce. By continuously promoting the establishment of a sound long-term mechanism and enhancing work efficiency and services, the company has realized harmonious, healthy and innovative development, earning recognition and praise from employees and various sectors of society.
The company has fulfilled its social responsibilities by establishing volunteer service teams. During the COVID-19 pandemic, it supplied pandemic prevention materials and stored and distributed COVID-19 vaccines in Tianjin. These moves contributed to the smooth and orderly progress of Tianjin’s pandemic response, building a solid immune barrier for Beijing, the capital of China.
The company has actively served the communities and society, ensured medication safety for the general public, and made contributions to a healthy China.